摘要
目的研究奥扎格雷治疗短暂性脑缺血发作(TIA)的临床效果。方法将符合标准的入选病例分为:实验组47例,给予奥扎格雷钠治疗;对照组45例,给予阿司匹林肠溶片口服,其余原发病等治疗措施一致,疗程均为14d,治疗前后均行血液流变学实验室检查,观察临床疗效并随访90d。结果2组临床疗效及血浆粘度比较,差异有显著意义(P<0.05);实验组较对照组的基本治愈率明显提高(76.60%比46.67%,P<0.05),血液流变学改善明显(P<0.05)。结论奥扎格雷治疗TIA效果确切,可降低TIA病人复发率及脑梗死的发生率。
Objective：To observe the clinical effect of Ozagrel on transient cerebral ischemia.Methods：Patients with transient ischemic attack were divided into the experiment group and the control group.47 patients in experiment group were treated with Ozagrel for 14 days,and 45 patients in control group were treated with enteric-coated tablet of Acenterine for 14 days.The patients received the examination of haemorheology before and after treatment,and were followed up 90 days.Results：There was significant different between two groups in the clinical effect and the plasma viscosity（P0.05）;the basic recovery rate of the experiment group was obviously higher than the control group（76.60%VS46.67%,P0.05,and the plasma viscosity improved obviously than the control group（P0.05）.Conclusion：There is exact effect of Ozagrel in transient cerebral ischemia,and it can decrease the recurrence rate of transient cerebral ischemia and the incidence rate of cerebral infarction in patients.
出处
《井冈山医专学报》
2009年第6期4-5,共2页
Journal of Jinggangshan Medical College
